Cusumano Ana Maria, Di Gioia Cristina, Hermida Osvaldo, Lavorato Carlos
Latin American Registry of Dialysis and Transplantation, Ardes:Guemes 3848, 2do A, 1425 Buenos Aires, Argentina.
Kidney Int Suppl. 2005 Aug(97):S46-52. doi: 10.1111/j.1523-1755.2005.09708.x.
Latin America is a conglomerate of adjacent countries having in common a Latin extraction and language (Spanish or Portuguese) and exhibiting extreme variations in socioeconomic status. The Latin American Society of Nephrology and Hypertension Dialysis and Renal Transplantation Registry was created in 1991. Annual data are sent by local societies in 3 forms: patient, center, and country. The prevalence of renal replacement therapy (RRT) (all modalities) increased from 119 patients per million population (pmp) in 1991 to 349 pmp in 2001; the acceptance rate was 91.7 pmp in 2001. Dialysis prevalence was 277 pmp; hemodialysis was the predominant modality, except in Mexico (86% on peritoneal dialysis). The highest dialysis prevalence and acceptance rates were reported by Puerto Rico, Uruguay, and Chile. Among incident patients, diabetic nephropathy (33%) and nephroangioesclerosis (32%) were the primary causes; 38% were older than 65 years old. Renal transplants increased from 3.7 pmp in 1987 to 13.7 pmp in 2001. In 2003, 6357 transplants were performed (55% living donor); the cumulative number performed since 1987 reached 55,947. Prevalence and incidence are low because not all patients with end-stage renal disease have access to RRT because of restricted availability, difficulties in referral, and inequities in coverage. The annual increase in the number of patients on RRT (8%-10%) is higher, proportionally, than the annual growth of the Latin American population in general (1.5%). Efforts must be focused on prevention and treatment of chronic kidney disease, especially in diabetic and older patients, and in implementing better organ donation programs to improve the pool of cadaveric donors.
拉丁美洲是由一些相邻国家组成的集合体,这些国家有着共同的拉丁裔血统和语言(西班牙语或葡萄牙语),并且在社会经济地位方面存在极大差异。拉丁美洲肾脏病、高血压、透析及肾移植学会注册机构创建于1991年。当地学会以三种形式报送年度数据:患者、中心和国家层面的数据。肾脏替代治疗(RRT,所有方式)的患病率从1991年的每百万人口119例患者增加到2001年的每百万人口349例;2001年的接受率为每百万人口91.7例。透析患病率为每百万人口277例;血液透析是主要方式,但墨西哥除外(86%采用腹膜透析)。波多黎各、乌拉圭和智利的透析患病率和接受率最高。在新发病例患者中,糖尿病肾病(33%)和肾血管硬化症(32%)是主要病因;38%的患者年龄超过65岁。肾移植数量从1987年的每百万人口3.7例增加到2001年的每百万人口13.7例。2003年进行了6357例移植手术(55%为活体供体);自1987年以来累计进行的移植手术数量达到55947例。患病率和发病率较低,原因是由于可及性受限、转诊困难以及覆盖范围不平等,并非所有终末期肾病患者都能获得肾脏替代治疗。接受肾脏替代治疗的患者数量的年增长率(8% - 10%)按比例高于拉丁美洲总体人口的年增长率(1.5%)。必须将工作重点放在慢性肾脏病的预防和治疗上,尤其是糖尿病患者和老年患者,同时要实施更好的器官捐赠项目,以增加尸体供体数量。